Prevalence and determinants of complementary and alternative medicine use among infertile patients in Lebanon: a cross sectional study by Ghina S Ghazeeri et al.
Ghazeeri et al. BMC Complementary and Alternative Medicine 2012, 12:129
http://www.biomedcentral.com/1472-6882/12/129RESEARCH ARTICLE Open AccessPrevalence and determinants of complementary
and alternative medicine use among infertile
patients in Lebanon: a cross sectional study
Ghina S Ghazeeri1, Johnny T Awwad1, Mohamad Alameddine2, Zeina MH Younes3 and Farah Naja3,4*Abstract
Background: Complementary and alternative medicine (CAM) is widely used for the treatment of infertility. While
the Middle East and North Africa region has been shown to house one of the fastest growing markets of CAM
products in the world, research describing the use of CAM therapies among Middle-Eastern infertile patients is
minimal. The aim of this study is to examine the prevalence, characteristics and determinants of CAM use among
infertile patients in Lebanon.
Methods: A cross sectional survey design was used to carry out face-to-face interviews with 213 consecutive
patients attending the Assisted Reproductive Unit at a major academic medical center in Beirut. The questionnaire
comprised three sections: socio-demographic and lifestyle characteristics, infertility-related aspects and information
on CAM use. The main outcome measure was the use of CAM modalities for infertility treatment. Determinants of
CAM use were assessed through the logistic regression method.
Results: Overall, 41% of interviewed patients reported using a CAM modality at least once for their infertility. There
was a differential by gender in the most commonly used CAM therapies; where males mostly used functional foods
(e.g. honey & nuts) (82.9%) while females mostly relied on spiritual healing/prayer (56.5%). Factors associated with
CAM use were higher household income (OR: 0.305, 95% CI: 0.132–0.703) and sex, with females using less CAM
than males (OR: 0.12, 95% CI: 0.051–0.278). The older patients were diagnosed with infertility, the lower the odds of
CAM use (p for trend <0.05). Almost half of the participants (48%) were advised on CAM use by their friends, and
only 13% reported CAM use to their physician.
Conclusions: The considerably high use of CAM modalities among Lebanese infertile patients, added to a poor
CAM use disclosure to physicians, underscore the need to integrate CAM into the education and training of health
professionals, as well as enhance infertile patients' awareness on safe use of CAM products.
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reproduction in any medium, provided the orpresently considered to be part of conventional medi-
cine” [1]. According to the World Health Organization
(WHO), more than three-quarters of the world’s pop-
ulation use complementary and alternative medicine
(CAM) for health care. Up to date, there is still inad-
equate data concerning the potential benefits or risks
attributed to the use of CAM [2]. Moreover, exchange of
information on CAM use between the patient and phys-
ician has also been shown to be scarce [1]. The most
reported reasons for the increase in the use of CAM in-
clude the absence of perceived efficacy and experience
of adverse effects with conventional medicine, a perceivedal Ltd. This is an Open Access article distributed under the terms of the Creative
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iginal work is properly cited.
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that use of CAM therapies allows users more active in-
volvement in treatment and in healthcare decisions [3-5].
Infertility has been identified by the WHO as an inter-
national public health concern, affecting an estimated
72.4 million women in year 2007 [6,7].
While assisted reproductive technologies (ART) serve
as promising treatment options for these patients to
achieve parenthood, they do not always prove to be suc-
cessful, and the expense associated with their utilization
has proven to be a burden, leaving couples feeling “des-
perate” to try anything to conceive [4,5,8]. Previous
studies about prevalence of CAM use among infertility
patients reported estimates between 30 and 60% [1,9-11].
While the Middle East and North Africa region has
been shown to house one of the fastest growing markets
of CAM products in the world [12], research describing
the use of CAM therapies among Middle-Eastern infer-
tile patients is minimal. A recent study on the use of
complementary and alternative medicines by a sample of
Turkish women for fertility enhancement found that
82% of study participants have used CAM at least once
for their infertility problem [4]. In Lebanon, no data
exists on the prevalence, types, characteristics, and rea-
sons for using CAM among infertile couples. With
Lebanon showing the lowest fertility rate among the
Arab countries [total fertility rate dropping from 3.2 in
the year 2004 to 1.8 in the year 2009 [13-15], it may be
hypothesized that couples are increasingly seeking alter-
native and complementary treatment modalities.
The lack of systematic information on the prevalence,
types and mode of CAM use for the treatment of infer-
tility in the Arab world in general, and Lebanon in par-
ticular, has hindered public efforts to enhance the safety
of public consumption and slowed down the integration
of CAM treatments into mainstream medicine.
The purpose of this study is to examine the frequency,
types, modes and determinants of CAM use among cou-
ples seeking infertility treatment in Lebanon.
Methods
A cross sectional survey was undertaken at the Assisted
Reproductive Technology (ART) Unit at a major tertiary
hospital in Beirut, American University of Beirut Med-
ical Center, Lebanon. Ethical approval was obtained from
the Institutional Review Board (IRB) at the American Uni-
versity of Beirut (AUB). “During the interview, a semi struc-
tured questionnaire was completed (Additional file 1)”. The
ART unit, initiated in 1993, is the largest in the coun-
try, accepting patients rom fall of the Lebanese governor-
ates and performing between 80 and 120 cycles per
month, including intra-uterine insemination (IUI), in-vitro
fertilization (IVF), and intracytoplasmic sperm injection
(ICSI). The ART unit team consists of four specializedphysicians, three embryologists and four nurses. Between
January 2011 and August 2011, all patients (males and
females) attending a routine visit at the ART unit were
approached to complete an anonymous questionnaire
about their use of CAM. When couples presented to the
unit, the partner receiving treatment was invited to par-
ticipate in the study. To be included in the study, patients
had to be over 18 years of age, diagnosed with infertility
for a minimum of one year and be conversant in either
the English or Arabic language. All eligible patients were
approached by a trained female nurse. Interviews took
place in the visit room individually and lasted approxi-
mately 15 minutes. Subject’s written consent was
obtained.
A face-to-face interview was undertaken with consecu-
tive infertile patients attending the ART unit at AUB-MC.
During the interview, a semi structured questionnaire
was completed.
The first draft of the questionnaire was drafted by an
expert panel including two physicians, a health manage-
ment professor and an epidemiologist and was based on
a synthesis of tools used in similar studies [4,10]. To en-
hance the content validity of this questionnaire and en-
sure its appropriateness to the local cultural context, a
pilot study involving a sample of 15 subjects was carried
out. Certain culturally sensitive items were identified
and in turn were excluded, such as the number of sexual
partners in the past and the age at which sexual activity
was commenced. The final version of the questionnaire
consisted of three sections. The first section included
questions about the socio-demographic and lifestyle
characteristics, such as age, sex, religion, number of
years being married, education, income, living with par-
ents-in-law, health insurance, smoking status (and num-
ber of years smoked) and self-perceived level of stress.
Subjects were considered “insured” if they were found to
have private and/or public insurance. Self-perceived
stress was recorded as a number from 0 to 10, with a
value of 0 being the lowest, indicating “no stress”, and a
value of 10 being the highest, indicating “extreme stress”
[16]. The second section of the questionnaire addressed
aspects of the subject’s infertility, such as the age at diag-
nosis, kinship to spouse, presence of fertility problems in
the family, duration of infertility, barriers to adherence
to treatment, and conventional treatment modalities that
have been utilized. In the last section of the question-
naire, participants were asked about the types of CAM
treatments used since diagnosis with infertility for the
purpose of improving their condition, frequency of use,
the provider of CAM modalities, disclosure of CAM use
to the physician, usefulness of CAM, side effects and
purpose of use. For the purpose of this study, side effects
referred to any unpleasant event that could be experi-
enced by the patient as a result of his/her use of a
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range from psychological distress to serious medical
condition. Use of CAM was defined as the use of any
one or more CAM type for the purpose of infertility
treatment since diagnosis.
The data was described by frequencies and per-
centages and by means and standard deviations for
categorical and continuous variables respectively. The
relationship between the various demographic and
infertility-related characteristics and use of CAM was
assessed by estimating odds ratios (OR) and 95% confi-
dence intervals (CI) using logistic regression with “use
of CAM” as the outcome variable. Multivariate logistic
regression modeling was used to assess the predictors
of CAM use. Variables were put in the model in order
of strength of their association with CAM use as per
the univariate analysis. The effect of each variable on
the model was assessed and this variable was kept in if it
significantly contributed to a better fit of the model.
Statistical significance was set at p <0.05, with all tests
being two-sided. SPSS 18.0 software was utilized to
analyze the obtained data.
Results
Descriptive analyses
Out of the 262 patients approached, 213 agreed to par-
ticipate in the study (response rate: 81.3%). Lack of suffi-
cient time to spend on the interview and fear of name
disclosure were the main reasons that were reported for
the refusal to participate. Analysis of findings showed
that 41% of patients have used a form of CAM at least
once as a treatment for their infertility. When “prayer”
was excluded from the definition of CAM, prevalence of
CAM use in the study population became 23%.
Demographic, lifestyle, reproductive and infertility re-
lated characteristics of the study population are pre-
sented in Table 1. Study participants’ mean age was 34.7
± 6.4 years, with no significant difference between users
and non users of CAM. Among the socio-demographic
factors considered in this study, sex, years of marriage,
income, education and religion were found to be sig-
nificantly associated with the use of CAM. The odds of
using CAM were significantly lower among females (OR:
0.24, CI: 0.13–0.44). Being married from more than
7 years was associated with a significantly higher odd of
using CAM (OR: 2.35, CI: 1.21–4.56). Patients with
monthly income ranging between $1000 and $2000
and greater than $2000 were less likely to use CAM
as compared to patients with income less than $1000.
Higher education (university and college levels) was
associated with lower prevalence of CAM use (OR:
0.35, CI: 0.20–0.62). Use of CAM was significantly lower
among Christian participants as compared to Muslim
patients (OR: 0.44, CI: 0.21–0.92). As for infertilityrelated characteristics, prevalence of CAM use decreased
with increasing age at diagnosis with infertility and
increased with longer duration of infertility (OR: 1.11,
CI: 1.04–1.18).
The types and modes of CAM used by study partici-
pants are presented in Table 2. Types of CAM were
divided into dietary supplements and spiritual/prayer
therapy. Dietary supplements included vitamins and
minerals, over the counter supplements, herbal therapies
and functional foods. Included among the over the
counter supplements are fish oils such as salmon and
cod liver oils, omega-3 supplements, and products from
general nutrition centers. Herbal therapies include plants
that are consumed for their claimed health benefits, and
encompass remedies such as feverfew, garlic, black seed,
ginger, ginkgo, and Asian ginseng.[17] “Functional foods”
included any foods that were perceived as having a
fertility-enhancing property beyond their basic function;
such as honey, and foods containing essential fats (e.g.
fish, nuts and seeds). For the purpose of this study, spir-
itual/prayer therapy referred to any religion-related ac-
tivity practiced to improve fertility. The most commonly
used CAM treatment among males was found to be
functional foods (82.9%), whereas spiritual therapy or
“prayers” and herbal therapies, were the most commonly
used CAM treatments among females (56.5% and 43.5%
for spiritual and herbal therapies, respectively).
Among the CAM users, 90.2% of the males reported
using CAM in order to improve their sperm characteris-
tics (sperm motility, production and/or quality) and 87%
of female participants reported using CAM in order to
enhance their chances of achieving a pregnancy. Other
reasons for CAM use reported by patients included re-
laxation, enhancing psychological well-being or strength-
ening energy.
When asked about how they chose the CAM modality
used, almost half of the participants indicated referral by
friends (48.3%) and influence by media (33.3%). Only
6.9% (n = 6) of patients used CAM because of a referral
by a health care practitioner. The use of CAM among
study participants was regular for the majority of pa-
tients (two or more times per week for a minimum of
one month) (70.1%). Factors that drove patients to
utilize CAM were “belief in its advantages” (56.3%), fol-
lowed by “trying CAM because of a suggestion” (51.7%),
with a few reporting their uptake of CAM to be due to
“dissatisfaction with conventional medicine” (9.2%) and
feeling that they “had no other alternative” (11.5%). Out
of the 87 users of CAM, only 11 patients (12.6%)
reported their use of CAM to their physician. Reported
reasons for not using CAM were that the physician had
not prescribed them (53.2%), followed by the lack of be-
lief in the benefits of CAM as enhancers of fertility
(48.4%) (Table 2).









Age (years) (mean ± SD) 34.7 ± 6.4 34.9 ± 6.7 34.6 ± 6.3 1.01 (0.97-1.05)
Sex (n,%)
Male 63 (29.6%) 41 (47.1%) 22 (17.5%) 1
Female 150 (70.4%) 46 (52.9%) 104 (82.5%) 0.24 (0.13-0.44)
Religion (n,%)
Muslim (Sunni, Shiite, Druze) 164 (78.5%) 74 (86.0%) 90 (73.2%) 1
Christian 45 (21.5%) 12 (14.0%) 33 (26.8%) 0.44 (0.21-0.92)
Years Married (n,%)
1-3 years 97 (45.5%) 34 (39.1%) 63 (50.0%) 1
4-6 years 57 (26.8%) 20 (23.0%) 37 (29.4%) 1.00 (0.51-1.99)
≥ 7 years 59 (27.7%) 33 (37.9%) 26 (20.6%) 2.35 (1.21-4.56)
p for trend <0.001
Household Income (n,%)
<$1000/month 90 (42.3%) 51 (58.6%) 39 (31.0%) 1
$1000-2000/month 47 (22.1%) 17 (19.5%) 30 (23.8%) 0.43 (0.21-0.90)
>$2000/month 76 (35.7%) 19 (21.8%) 57 (45.2%) 0.26 (0.13-0.50)
p for trend <0.001
Educational level (n,%)
Illiterate to Baccalaureate 86 (40.4%) 48 (55.2%) 38 (30.2%) 1
Diploma/University 127 (59.6%) 39 (44.8%) 88 (69.8%) 0.35 (0.20-0.62)
Living with parents-in-law (n,%)
No 196 (92.0%) 77 (88.5%) 119 (94.4%) 1
Yes 17 (8.0%) 10 (11.5%) 7 (5.6%) 2.21 (0.81-6.05)
Health Insurance (n,%)
Uninsured 59 (27.7%) 29 (33.3%) 30 (23.8%) 1
Insured 154 (72.3%) 58 (66.7%) 96 (76.2%) 0.63 (0.34-1.15)
Smoking status (n,%)
Non-smokera 177 (83.1%) 68 (78.2%) 109 (86.5%) 1
Smoker 36 (16.9%) 19 (21.8%) 17 (13.5%) 1.79 (0.87-3.68)
No. of years (mean ± SD) 16.0 ± 7.4 17.2 ± 7.3 14.6 ± 7.4 1.05 (0.96-1.16)
Self-perceived stress b
≤5 103 (48.4%) 39 (44.8%) 64 (50.8%) 1
>5 110 (51.6%) 48 (55.2%) 62 (49.2%) 1.27 (0.73-2.20)
Age at diagnosis (mean ± SD)
< 20 years 19 (8.9%) 14 (16.1%) 5 (4.0%) 1
20-30 years 91 (42.7%) 38 (43.7%) 53 (42.1%) 0.26 (0.09-0.77)
>30 years 103 (48.4%) 35 (40.2%) 68 (54.0%) 0.18 (0.06-0.55)
p for trend <0.001
Kinship to spouse (n,%)
Not related 183 (85.9%) 72 (82.8%) 111 (88.1%) 1
Related 30 (14.1%) 15 (17.2%) 15 (11.9%) 1.54 (0.71-3.35)
Family fertility problems (n,%)
None 174 (81.7%) 72 (82.8%) 102 (81.0%) 1
Yes 39 (18.3%) 15 (17.2%) 24 (19.0%) 0.89 (0.43-1.81)
Duration of Infertility (mean ± SD) 4.3 ± 4.8 5.6 ± 5.7 3.4 ± 3.9 1.11 (1.04-1.18)
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Table 1 Demographic, lifestyle, reproductive and infertility-related characteristics of users and non-users of CAM
treatments* (Continued)
Barriers to adherence to treatment
No barriers 85 (39.9%) 32 (36.8%) 53 (42.1%) 1
Barriers 128 (60.1%) 55 (63.2%) 73 (57.9%) 1.25 (0.71-2.19)
Current treatment (Males & Females) (n,%)
No IUI or IVF treatmentc 43 (20.2%) 14 (16.1%) 29 (23.0%) 1
IUI or IVF procedure 170 (79.8%) 73 (83.9%) 97 (77.0%) 1.56 (0.77-3.16)
*Values in this table represent n and % for the categorical variables and means ± SDs for the continuous variables.
** OR and their 95% CI were derived using a univariate logistic model with CAM use as the dependent variable.
a Indicates both non-smokers and past-smokers.
b Self-perceived stress was assessed using a scaling system ranging from 0–10 (0 = no stress at all, 10 = extreme stress).
c Includes patients not receiving any treatment, patients receiving medications without IUI and/or surgery.
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examining the association of the various demographic
and infertility-related characteristics and CAM use are
presented in Table 3. Sex, age at diagnosis with infertil-
ity, household income, and type of infertility treatment
were independent predictors of CAM use. Prevalence of
CAM use was lower among females (OR: 0.12, CI:
0.051–0.278). In addition, the older the patients were
diagnosed with infertility the less likely they were to use
a CAM modality (p for trend < 0.001). Subjects belong-
ing to the highest income bracket (>2000$/month) used
less CAM therapies as compared to those in the lowest
income bracket (<1000$/month) (OR: 0.305, CI: 0.132–
0.703). Subjects undergoing IUI or IVF procedures were
more likely to be CAM users (OR: 20.918; CI: 1.1–7.75).
Age, barriers to medical treatment adherence, years of
marriage, and religion were not found to reach statistical
significance after multivariate adjustment.
Discussion
This study investigated the prevalence and determinants
of CAM use among infertile patients attending the
Assisted Reproductive Technology (ART) Unit at the
American University of Beirut Medical Center, a major
tertiary hospital in Beirut, Lebanon. We found that 41%
of infertile patients used a form of CAM at least once as
a treatment for their infertility. Studies on prevalence of
CAM use among infertile patients reported a wide range
of estimates. Similar to our findings, a study from the
United Kingdom assessing CAM use among 400 infertile
women found 40% of participants to have used CAM as
a therapy for their failure to conceive [11]. Furthermore,
in Denmark, a prospective observational cohort study
reported a 31% prevalence of CAM use among infertile
women [1]. However, in the United States, a lower
prevalence was found in a cohort study of 428 couples
seeking infertility treatment (29%) [10], while a relatively
high prevalence (82%) of CAM use among Turkish infer-
tile patients was recently reported [4]. Possible reasons
for the discrepancy in prevalence estimates reported inthe literature could be the heterogeneity of CAM prac-
tices, where there may be differences in what is defined
as a CAM treatment and what types of CAM modalities
are included in the studies. Other reasons may be differ-
ences in study design as well as in cultural backgrounds
which could lead to differential patterns of use.
Our findings showed that among women, “spiritual
healing”, specifically “prayer” and “religious vows”, were
the most commonly practiced CAM therapies. Religious
vows involve making a promise to perform a specific
deed once the prayer has been answered. Lebanon seems
to be a country whereby religion is highly influential on
people’s daily practices, with prayer being an integral
part of the culture. Spiritual healing has been suggested
to have potentially beneficial effects through its
provision of hope and in turn, a positive attitude towards
patients’ conventional infertility treatment, as was sug-
gested in the Turkish study assessing CAM use for infer-
tility enhancement [4].
In this study, the most commonly utilized CAM ther-
apy by men was “functional foods”, specifically fish, nuts,
and seeds, honey and royal honey. Seeds and nuts have
been reported by complementary medicine practitioners
to be beneficial for treating infertility due to their poly-
unsaturated fatty acid content [18]. Honey has been
traditionally used among the Lebanese and other Arab
populations for treatment of many diseases, such as the
common cold and cough, in addition to infertility. Royal
honey, also called “food for queens”, is a honey bee se-
creted from the glands in the hypopharynx of worker
bees that is believed to give the queen bees their longev-
ity and fertility. Furthermore, honey is mentioned in
both the Quran (the Muslim Holy Book) and the Holy
Bible as having the feature of healing mankind [19,20].
In addition to prayers and functional foods, our results
showed that herbal therapies were used by men and
women for infertility treatment, including blackseed,
ginseng, maca, and marjoram. Blackseed, the common
name for Nigella sativa L. seeds, is traditionally used as
a spice and food preservative. Although hexane extracts
Table 2 Types and modes of CAM use among couples seeking infertility treatment (n = 87)
Frequency n (%)
Types of CAM modalities used among males (n,%)*
Functional foods 34 (82.9%)
Spiritual/ prayer therapy 13 (31.7%)
Vitamins and minerals 12 (29.3%)
Herbal therapies 5 (12.2%)
Over the counter supplements 2 (4.9%)
Types of CAM modalities used among females (n,%)*
Spiritual/ prayer therapy 26 (56.5%)
Herbal therapies 20 (43.5%)
Over the counter supplements 16 (34.8%)
Vitamins and minerals 7 (15.2%)
Reasons for CAM use among males (n,%)*
Improvement of sperm characteristics 37 (90%)
Relax, feel better psychologically and provide energy 12 (29.3%)
Relief of other reproductive related conditions 2 (4.9%)
Reasons for CAM use among females (n,%)* 6 (6.9%)
Enhance chances of pregnancy 40 (87%)
Relax, feel better psychologically and provide energy 19 (41.3%)
Uterine and ovulatory related reasons 17 (37%)
Relief of other reproductive related conditions 3 (4.3%)
How CAM was chosen (n,%)*
Personal choice 22 (25.3%)
Friends 42 (48.3%)
Media (Internet, magazines, TV) 29 (33.3%)
Health practitioner 6 (6.9%)
Health food shop 2 (2.3%)
Family beliefs 28 (32.2%)
Frequency of CAM use (n,%)
Only once 12 (13.8%)
Regularly (2 or more per week for min a month) 61 (70.1%)
Rarely 14 (16.1%)
Why have you used CAM (n,%)*
Disappointment from conventional medicine 8 (9.2%)
Feeling of having no alternative 10 (11.5%)
Belief in the advantages of CAM 49 (56.3%)
Trying because of a suggestion 45 (51.7%)
Feeling after CAM use (n,%)
Feeling stronger, physically better and in good psychological condition 43 (49.4%)
No change or physically worse and in bad psychological condition 44 (50.6%)
Usefulness of CAM (n,%)
Not at all 32 (36.8%)
Some 29 (33.3%)
A lot 15 (17.2%)
Can’t tell 11 (12.6%)
Reporting CAM use to the doctor (n,%)
No 76 (87.4%)
Yes 11 (12.6%)
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Table 2 Types and modes of CAM use among couples seeking infertility treatment (n = 87) (Continued)
Side effects from CAM use (n,%)
No 81 (93.1%)
Yes 6 (6.9%)
Use of CAM again
No 34 (39.1%)
Yes 53 (60.9%)
Recommend CAM to other infertile patients
No 42 (48.3%)
Yes 45 (51.7%)
Reasons for not using CAM among non-users (n = 126) *
Never heard of it 6 (4.8%)
Afraid of the side effects 25 (19.8%)
Do not believe in it 61 (48.4%)
The doctor didn’t prescribe it 67 (53.2%)
Not to have additional burden 12 (9.5%)
Other** 26 (20.6%)
*Columns do not sum to 100% due to the option of multiple answers.
**Includes: waste of time, lack of proof of their benefit, not in need for them yet, lack of advice on their use, knowing the problem is purely medical, presence of
co morbidities, unsafe, unhelpful in this case, prefer conventional treatment.
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tility activity in rats [21], it is a common belief among
muslims and Christians in Lebanon and other countries
of the Middle East that this seed possesses curative abil-
ities for a wide range of diseases, including fertility [22].
Ginseng, maca and marjoram are herbal plants that have
been suggested in the literature to confer beneficial
effects on male fertility [23-25].
Although minimal or no risk has been associated with
prayer and the use of functional foods for infertility
treatment, herbal therapies have been reported to ad-
versely affect chances of pregnancy and health. Phy-
toestrogens present in herbal supplements have been
suggested to have negative estrogenic effects on implant-
ation [1]. Furthermore, the side effects associated with a
number of herbs is still unknown [2].
It is disconcerting that only 7% of the CAM users in
our sample reported being advised on CAM modalities
by their “health practitioner”, and the disclosure rate of
CAM use to the physician was found to be low (13%).
These findings are consistent with previous research,
where in a review of qualitative and quantitative studies
evaluating the disclosure of patients’ CAM use to med-
ical practitioners, Robinson & McGrail [26] reported dis-
closure rate to be as low as 23% in some of their
included studies. Possible reasons for why patients seem
to find it difficult to report their CAM use to their phys-
ician include the fear of receiving a negative reaction
and disapproval from their physician, believing that their
physician did not need to know about their CAM use,
and/or because their physician had not inquired about
their CAM use [26,27]. This low disclosure rate of CAMuse is alarming and may warrant the need to train physi-
cians on probing their patients on CAM use [22]. Health
care practitioners need to become more aware of the in-
creasing prevalence of their patients’ CAM use in order
to be able to improve the provision of evidence-based
knowledge to their patients concerning the use of these
therapies [28].
Our results indicated that sex, age at infertility diagno-
sis, household income and the type of infertility treat-
ment were independent correlates of CAM use. Males
were found to be at higher odds of using CAM. This is
in contrast to other studies that found women to be at
higher odds of using CAM compared to men [11,27,29].
A possible explanation of our finding could be the fact
that in the Arab culture, including Lebanon, fertility is
linked to manhood, leading male infertility to be an issue
for masculinity, marriage and family life [30]. As such,
males in this culture may be placing more attention on
treatments to enhance their fertility as a mean to restore
their “manhood” [30]; such assumption would need to
be substantiated in future sociological/ anthropological
research.
Our results showed that higher income was associated
with lower use of CAM therapies. In previous studies of
determinants of CAM use, household income was consist-
ently positively correlated with CAM use [10,11,31]. This
relationship between CAM use and a high income status
in other studies could be attributed to the fact that couples
of high income would be more likely to afford the cost of
CAM, in addition to their infertility treatments [11]. In
those studies, the most widely used CAM were costly mo-
dalities, such as acupuncture and massage therapy. In our
Table 3 Multivariate Logistic Regression Model with OR
estimates and 95% CI for the association between
demographic and fertility-related factors and the use of








< 20 years 1 —
20-30 years 0.17 0.05-0.60
> 30 years 0.09 0.02-0.39
p for trend <0.001
Barriers to adherence to treatment
No barriers 1 —
Barriers 0.96 0.48-1.95
Religion
Muslim (Sunni, Shiite, Druze) 1 —
Christian 1.06 0.42-2.65
Years Married
1–3 years 1 —
4-6 years 0.92 0.40-2.11
≥7 years 2.08 0.91-4.78
p for trend <0.001
Household Income
<1000 $ 1 —
1000-2000$ 0.43 0.18-1.04
>2000$ 0.31 0.13-0.70
p for trend <0.001
Type of treatment
No IUI or IVF treatment 1 —
IUI or IVF procedure 2.92 1.10-7.75
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CAM modalities were functional foods and prayers among
male and female patients, respectively; both of which are
therapies that are considered of lower cost, and thus may
be less likely to pose as a financial burden to patients of
lower income.
Several limitations are to be considered in this study.
First, the fact that recruitment of participants took place
in an Assisted Reproductive Technologies Unit might
have led to an underestimation of the prevalence of
CAM use since surveyed subjects have a potential bias
toward conventional treatment. Second, given that parti-
cipants in this study were recruited from one clinical
setting raises questions concerning the generalizability of
our findings; however, the ART unit at the American
University of Beirut Medical Center is considered thelargest unit for infertility treatment in Lebanon (as re-
flected by the high number of cycles it performs per
month) and is a major referral center for the treatment
of infertility from all other governorates. Third, the cross
sectional nature of the study does not allow establishing
causality between the various correlates and the CAM
use. Finally, the possibility of a recall bias cannot be
ruled out in self reports concerning CAM use.
Conclusions
Our results showed that a considerable proportion of
patients used CAM therapies for infertility treatment.
“Functional foods” and “spiritual healing” were the most
commonly used CAM modalities by our sample of male
and female patients, respectively. CAM use is associated
with lower household income, male gender, younger age
at infertility diagnosis, and undergoing ART procedures
for infertility treatment. The considerably high use of CAM
modalities among Lebanese infertile patients, added to a
poor CAM use disclosure to physicians suggests the
need for physicians to initiate discussions with their pa-
tients regarding CAM use. In addition future research is
needed in areas such as CAM education of healthcare
workers and patients’ awareness on the proper use of the
CAM modalities.
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